JP2015510935A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510935A5 JP2015510935A5 JP2015501777A JP2015501777A JP2015510935A5 JP 2015510935 A5 JP2015510935 A5 JP 2015510935A5 JP 2015501777 A JP2015501777 A JP 2015501777A JP 2015501777 A JP2015501777 A JP 2015501777A JP 2015510935 A5 JP2015510935 A5 JP 2015510935A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- dtpa
- particles
- average diameter
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 claims 21
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims 11
- 239000002245 particle Substances 0.000 claims 6
- 150000003751 zinc Chemical class 0.000 claims 5
- 239000011362 coarse particle Substances 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 3
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical group [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000004246 zinc acetate Substances 0.000 claims 2
- 206010065973 Iron Overload Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229920003169 water-soluble polymer Polymers 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261614333P | 2012-03-22 | 2012-03-22 | |
| US61/614,333 | 2012-03-22 | ||
| US201361771873P | 2013-03-03 | 2013-03-03 | |
| US61/771,873 | 2013-03-03 | ||
| PCT/US2013/031336 WO2013142258A1 (en) | 2012-03-22 | 2013-03-14 | Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015510935A JP2015510935A (ja) | 2015-04-13 |
| JP2015510935A5 true JP2015510935A5 (enExample) | 2016-05-12 |
Family
ID=48014341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501777A Ceased JP2015510935A (ja) | 2012-03-22 | 2013-03-14 | 封入ジエチレントリアミンペンタアセテート粒子の経口送達のための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9040091B2 (enExample) |
| EP (1) | EP2827853A1 (enExample) |
| JP (1) | JP2015510935A (enExample) |
| KR (1) | KR20140139563A (enExample) |
| AU (1) | AU2013235491A1 (enExample) |
| CA (1) | CA2867701C (enExample) |
| MX (1) | MX2014011123A (enExample) |
| WO (1) | WO2013142258A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6649262B2 (ja) * | 2014-02-18 | 2020-02-19 | メデシス・ファルマ・ソシエテ・アノニムＭｅｄｅｓｉｓ Ｐｈａｒｍａ Ｓ．Ａ． | 放射性核種及び金属のキレート剤を送達するための逆ミセルシステムの使用 |
| CO2018004165A2 (es) | 2015-10-23 | 2018-09-20 | Vifor Int Ag | Inhibidores de ferroportina |
| JP2018052884A (ja) * | 2016-09-29 | 2018-04-05 | 菊川 正 | 放射線核種キレート化剤を内包する経口投与剤 |
| JOP20180036A1 (ar) | 2017-04-18 | 2019-01-30 | Vifor Int Ag | أملاح لمثبطات فروبورتين جديدة |
| TW202102478A (zh) | 2019-04-01 | 2021-01-16 | 瑞士商威佛（國際）股份有限公司 | 新穎的鐵螯合物 |
| WO2024253935A1 (en) | 2023-06-05 | 2024-12-12 | Nanopharmaceutics, Inc. | Compositions and methods for oral delivery of sustained release crystalline prx-3140 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| NZ248813A (en) | 1992-11-25 | 1995-06-27 | Eastman Kodak Co | Polymeric grinding media used in grinding pharmaceutical substances |
| TW384224B (en) | 1994-05-25 | 2000-03-11 | Nano Sys Llc | Method of preparing submicron particles of a therapeutic or diagnostic agent |
| US5510118A (en) | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
| UA76810C2 (uk) * | 2001-12-10 | 2006-09-15 | Мерк Енд Ко., Інк. | Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок |
| US7910086B1 (en) * | 2005-01-04 | 2011-03-22 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
| EP1922150A1 (en) | 2005-07-07 | 2008-05-21 | Nanotherapeutics, Inc. | Process for milling and preparing powders and compositions produced thereby |
| AU2007259408B2 (en) * | 2006-02-17 | 2010-03-04 | Sri International | Oral DTPA for radionuclide chelation |
| CA2796853A1 (en) * | 2010-04-21 | 2011-10-27 | Hsing-Wen Sung | A pharmaceutical composition of nanoparticles |
-
2013
- 2013-03-14 AU AU2013235491A patent/AU2013235491A1/en not_active Abandoned
- 2013-03-14 CA CA2867701A patent/CA2867701C/en active Active
- 2013-03-14 WO PCT/US2013/031336 patent/WO2013142258A1/en not_active Ceased
- 2013-03-14 EP EP13713011.8A patent/EP2827853A1/en not_active Withdrawn
- 2013-03-14 JP JP2015501777A patent/JP2015510935A/ja not_active Ceased
- 2013-03-14 MX MX2014011123A patent/MX2014011123A/es unknown
- 2013-03-14 KR KR1020147028955A patent/KR20140139563A/ko not_active Ceased
- 2013-03-14 US US13/827,667 patent/US9040091B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015510935A5 (enExample) | ||
| MX2012004472A (es) | Forma farmaceutica oral solida contra el uso indebido y que tiene un perfil especifico de liberacion modificada. | |
| TWI539969B (zh) | Composition for oral use | |
| NZ707551A (en) | Prostacyclin compositions and methods for using the same | |
| JP2016065086A5 (enExample) | ||
| NZ626401A (en) | A novel formulation of naproxen | |
| WO2011146583A3 (en) | Nanoparticulate cinacalcet formulations | |
| JP2011046962A5 (enExample) | ||
| JP2009512663A5 (enExample) | ||
| ZA201708286B (en) | Orodispersible dosage unit containing an estetrol component | |
| NZ722952A (en) | Inhalable pharmaceutical compositions | |
| JP2016060682A5 (enExample) | ||
| HRP20170241T2 (hr) | Čvrsti oblici 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline | |
| JP2011506330A5 (enExample) | ||
| PH12013501846A1 (en) | A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide | |
| RU2012150444A (ru) | Продукт для ухода за полостью рта и способы его применения и производства | |
| RU2015110824A (ru) | Фармацевтическая или нутрицевтическая композиция с замедленным высвобождением и стойкостью к воздействию этанола | |
| JP2012012392A5 (enExample) | ||
| RU2015128794A (ru) | Композиция перорально распадающейся таблетки, обеспечивающая повышенную биодоступность | |
| MX2013007237A (es) | Peliculas y composiciones que comprenden las mismas. | |
| JP2014514391A5 (enExample) | ||
| RU2012136858A (ru) | Средство для полости рта по уходу за чувствительной эмалью | |
| JP2011503190A5 (enExample) | ||
| RU2017118329A (ru) | Частицы кадотрила | |
| JP2011251985A5 (enExample) |